The effects of discontinuing topiramate after a treatment period of 6 months in 818 patients with migraine, enrolled from 88 clinics in 21 countries in Europe, the UK and Turkey, are reported from University Duisburg-Essen, Germany
To monitor weight regain after therapy discontinuation in patients with migraine experiencing weight...
Sergio Carmona1, Osvaldo Bruera1,21Department of Neuro-otology and Pain and Headache, Instituto de N...
Abstract Increasing evidence shows that migraine, typi-cally considered as an episodic disease, is a...
Background Use of preventive therapy for migraine is often recommended for only 6-9 months, but no r...
L'autore è ricompreso nel TOPMAT-MIG-303 Investigators Group, il cui elenco è è riportato in calce a...
Abstract The majority of patients with migraine headaches are treated in non-specialized institution...
We reviewed the electronic records of 74 migraine patients treated with topiramate for more than 6 w...
Among the primary headaches, one of the most common is migraine. Modern principles of migraine thera...
OBJECTIVE: This is a randomized, double-blind versus placebo study aimed at evaluating the efficacy ...
The objectives of this paper are to evaluate the efficacy and tolerability of topiramate, given at t...
Abstract Objective Topiramate is a repurposed first-line treatment for migraine prophylaxis. The aim...
The purpose of this study was to evaluate the efficacy of topiramate in the treatment of chronic mi...
Steffen Naegel, Mark ObermannDepartment of Neurology, University of Duisburg-Essen, Hufelandstr. 55,...
Topiramate, FDA approved for migraine prophylaxis, is a promising treatment in IIH because it can re...
INTRODUCTION: Demographic and clinical variables were examined in a post hoc analysis of the PROlong...
To monitor weight regain after therapy discontinuation in patients with migraine experiencing weight...
Sergio Carmona1, Osvaldo Bruera1,21Department of Neuro-otology and Pain and Headache, Instituto de N...
Abstract Increasing evidence shows that migraine, typi-cally considered as an episodic disease, is a...
Background Use of preventive therapy for migraine is often recommended for only 6-9 months, but no r...
L'autore è ricompreso nel TOPMAT-MIG-303 Investigators Group, il cui elenco è è riportato in calce a...
Abstract The majority of patients with migraine headaches are treated in non-specialized institution...
We reviewed the electronic records of 74 migraine patients treated with topiramate for more than 6 w...
Among the primary headaches, one of the most common is migraine. Modern principles of migraine thera...
OBJECTIVE: This is a randomized, double-blind versus placebo study aimed at evaluating the efficacy ...
The objectives of this paper are to evaluate the efficacy and tolerability of topiramate, given at t...
Abstract Objective Topiramate is a repurposed first-line treatment for migraine prophylaxis. The aim...
The purpose of this study was to evaluate the efficacy of topiramate in the treatment of chronic mi...
Steffen Naegel, Mark ObermannDepartment of Neurology, University of Duisburg-Essen, Hufelandstr. 55,...
Topiramate, FDA approved for migraine prophylaxis, is a promising treatment in IIH because it can re...
INTRODUCTION: Demographic and clinical variables were examined in a post hoc analysis of the PROlong...
To monitor weight regain after therapy discontinuation in patients with migraine experiencing weight...
Sergio Carmona1, Osvaldo Bruera1,21Department of Neuro-otology and Pain and Headache, Instituto de N...
Abstract Increasing evidence shows that migraine, typi-cally considered as an episodic disease, is a...
DOI
Add to ORKG